Micropos Medical develops technologies that enhance the precision in radiotherapy of cancer. The RayPilot® is an electromagnetic tracking system that enables real time information of the target position for continuous localisation during the treatment.
The RayPilot® system is developed for prostate cancer but has the potential for future use in other tumor areas.
By using RayPilot®, our ambition is that clinics can reduce side effects, increase patient safety and get higher patient throughput which benefits patients and healthcare providers.
Micropos Medical AB (publ) is a company listed in Sweden on Spotlight Stock Market under the stock ticker MPOS.